Your browser doesn't support javascript.
loading
An integrated flow cytometry analysis of 286 mature B cell neoplasms identifies CD13 as a useful marker for diagnostic subtyping.
Lau, Hubert; Nagy, Alexandra; Atwater, Susan K; Cascio, Michael J; Ohgami, Robert S.
  • Lau H; Stanford University Medical Center, Stanford, California.
  • Nagy A; Stanford University Medical Center, Stanford, California.
  • Atwater SK; Stanford University Medical Center, Stanford, California.
  • Cascio MJ; Oregon Health Sciences University, Portland, Oregon.
  • Ohgami RS; Stanford University Medical Center, Stanford, California.
Int J Lab Hematol ; 40(6): 715-720, 2018 Dec.
Article en En | MEDLINE | ID: mdl-30066366

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia de Células B / Biomarcadores de Tumor / Linfoma de Células B / Antígenos CD13 / Neoplasias Hematológicas / Citometría de Flujo / Proteínas de Neoplasias Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia de Células B / Biomarcadores de Tumor / Linfoma de Células B / Antígenos CD13 / Neoplasias Hematológicas / Citometría de Flujo / Proteínas de Neoplasias Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article